Clinical Trials Logo

Filter by:
NCT ID: NCT03970395 Completed - Clinical trials for Nonsynostotic Plagiocephaly

Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

The aim of this trial is to evaluate the effectiveness of osteopathic manipulative therapy in reducing the asymmetries of skull in infants with nonsynostotic plagiocephaly.

NCT ID: NCT03969914 Completed - Acute Kidney Injury Clinical Trials

PEEP-induced Changed in RRI as Physiological Background of Ventilator-induced Kidney Injury

PRE-VIKI
Start date: May 1, 2019
Phase:
Study type: Observational

The renal Doppler resistive index (RRI) is a noninvasive tool that has been used to assess renal perfusion in the intensive care unit (ICU) setting. Many parameters have been described as influential on the values of renal RI. Mechanical ventilation is associated with significant increases in the risk of acute kidney injury (AKI). Ventilator-induced kidney injury (VIKI) is believed to occur due to changes in hemodynamics that impair renal perfusion. The investigators hypothesized that patients who need mechanical ventilation should have a different response in RRI when different levels of Positive end expiratory pressure (PEEP) are applied. Investigators wish to describe changing in RRI due to changes in PEEP and to verify whether these changes could partially explain the occurrence of VIKI

NCT ID: NCT03968627 Completed - Stroke Clinical Trials

Development of a National Protocol for Stroke Rehabilitation in a Multicenter Italian Institution

Start date: February 1, 2017
Phase:
Study type: Observational

Due to the importance to use standardized shared protocols in the rehabilitative setting of cerebrovascular diseases, an harmonization and redefinition of the Don Carlo Gnocchi Foundation rehabilitative model was carried out. Such process was in line with the Evidence Based approach of Cochrane Rehabilitation.

NCT ID: NCT03968471 Completed - Clinical trials for Ewing Sarcoma of Bone

Chemotherapy-induced Necrosis in Ewing Sarcoma

Start date: May 13, 2019
Phase:
Study type: Observational

This is single institution cases series review of histological and clinical data

NCT ID: NCT03967951 Completed - Clinical trials for Pancreatic Neuroendocrine Tumor

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Start date: March 23, 2019
Phase:
Study type: Observational

The aim of this study is to quantify inter-observer variability in delineating pancreatic neuroendocrine neoplasm (PanNEN) on Computerized Tomography (CT) images and its impact on radiomic features (RF), subsequently to this determination, to use CT texture analysis to predict, histological characteristics of PanNEN on CT scans.

NCT ID: NCT03967860 Completed - Obesity Clinical Trials

Role of Post Surgery CT Following Laparoscopic Vertical Sleeve Gastrectomy

LSG-CT
Start date: March 6, 2019
Phase:
Study type: Observational

Obesity is a extremely widespread condition in Europe and North America, burdened by a series of complications characterized by major morbidity and morbility. In recent years, bariatric surgery has progressively assumed a leading role in the treatment of morbid obesity and restrictive bariatric surgery procedures, such as laparoscopic vertical sleeve gastrectomy are common. The aim of the study is to retrospectively determine the value of postoperative CT after LSG as an early tool to identify risk factors for the subsequent development of gastric fistula and enable to stratify postoperative risk in asymptomatic patients and ensure effective management of these risk factors.

NCT ID: NCT03965585 Completed - Infertility, Female Clinical Trials

Office Hysteroscopy in Infertility Work-out: the Role of Endometrial Hyperplasia in Southern Italian Women

Start date: January 2, 2019
Phase:
Study type: Observational

To assess the prevalence of endometrial hyperplasia (EH), endometrial intraepithelial neoplasia (EIN) and endometrial carcinoma between obese and not obese women undergoing IVF techniques for primary or secondary infertility.

NCT ID: NCT03964415 Completed - Healthy Clinical Trials

A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals

MOSAICO
Start date: October 31, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the vaccine efficacy (VE) of a heterologous vaccine regimen utilizing Ad26.Mos4.HIV and aluminum phosphate-adjuvanted Clade C gp140 and Mosaic gp140 for the prevention of HIV-1 infection in HIV-1 seronegative cis-gender men and transgender individuals having sex with cis-gender men and/or transgender individuals.

NCT ID: NCT03963167 Completed - COPD Clinical Trials

Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

Start date: August 21, 2019
Phase:
Study type: Observational

The mean objectives are to evaluate the impact of BDP/FF/G fixed combination on health-status and adherence

NCT ID: NCT03962686 Completed - Clinical trials for Diabetes Mellitus, Type 2

Molecular Mechanisms and Carotid Atherosclerosis

Start date: January 1, 2015
Phase:
Study type: Observational

The role of methylase system and Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the accelerated atherosclerotic progression of diabetic patients is unclear. Authors will evaluate methylase activity and PCSK9 in carotid plaques of asymptomatic diabetic and non diabetic patients, as well as the effect of statin added to PCSK9 inhibitors (PCSK9i) therapy vs. statin alone in diabetic plaques. Plaques will be obtained from 43 type 2 diabetic and 30 non diabetic patients undergoing carotid endarterectomy. Diabetic patients will receive statin therapy (n 23) or statin plus PCSK9i (140 mg of evolocumab; n 20) or placebo (n 23) for 4 months before scheduled endarterectomy. Plaques will be analyzed for macrophages (CD68), T-cells (CD3), inflammatory cells (HLADR), methylase activity, nuclear factor (NF)-KB, tumor necrosis factor (TNF)-alpha, nitrotyrosine, matrix metalloproteinase (MMP) and collagen content (immunohistochemistry and enzyme- linked immunosorbent assay. Authors' study hypothesis is that methylase and PCSK9 over-activity will be associated with enhanced inflammatory reaction and NF-KB expression in diabetic plaques. Secondly, the inhibition of methylase activity in atherosclerotic lesions of diabetic patients by metformin plus SLGT2i might be associated with morphological and compositional characteristics of a potential stable plaque phenotype, possibly by down regulating NF-KB-mediated inflammatory pathways.